NEXIMMUNE (NEXI) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 7 53 sessions, August 8, 2025 to September 8, 2026
- Largest daily move
- +4900% close of September 12, 2025
- 1-year change
- -50% closing prices, August 8, 2025 to September 8, 2026
- 1-month change
- +0% closing prices, July 9, 2026 to September 8, 2026
Company Description
NEXIMMUNE (OTC: NEXI) is classified in the biotechnology industry within the Healthcare sector.
NEXI has declined 50.0% over the past year. The last closing price was $0.0001.
For FY2023, NEXIMMUNE reported net income of -$32.3M and diluted earnings per share of -$30.82.
This page collects what Stock Titan holds for NEXI, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
NEXIMMUNE (NEXI) closed at $0.0001 on September 8, 2026. Over the past 12 months, the price has lost 50.0%.
NEXI Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEXIMMUNE has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include offering, partnership, stock split, earnings, clinical trial. View all NEXI news →
SEC Filings
Financial Highlights
operating income reached -$33.0M, and net income was -$32.3M. Diluted earnings per share stood at -$30.82. The company generated -$31.4M in operating cash flow. The current ratio was 1.06, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in NEXIMMUNE (NEXI) currently stands at 112 shares, representing 0.0% of the float. Since October 2025, short interest has decreased by 44.8%.
Days to Cover History
Days to cover for NEXIMMUNE (NEXI) currently stands at 1000.0 days, up 99899% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
NEXI Company Profile & Sector Positioning
NEXIMMUNE (NEXI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NEXI often look at related companies in the same sector, including REGENERX BIOPHARMS INC (RGRX), Eloxx Pharmaceuticals, Inc. (ELOX), GRITSTONE BIO INC (GRTSQ), EFFECTOR THERAPUTCS INC (EFTR), and INNOVEREN SCIENTIFIC INC (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NEXI's relative position within its industry.